HRT Financial’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,607
Closed -$389K 3707
2025
Q4
$389K Buy
+22,607
New +$438K ﹤0.01% 2241
2024
Q2
Sell
-20,250
Closed -$3.09M 2146
2024
Q1
$3.09M Buy
+20,250
New +$3.37M 0.02% 409
2023
Q4
Sell
-5,388
Closed -$2.39M 2252
2023
Q3
$2.39M Buy
+5,388
New +$2.43M 0.02% 542
2023
Q2
Sell
-37,986
Closed -$22.6M 2387
2023
Q1
$22.6M Buy
+37,986
New +$21.3M 0.28% 54

Other funds holding AGL

HRT Financial's AGL Position: Q1 2026 in Review

HRT Financial sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 22,607 shares — an estimated $389K sold.

HRT Financial first reported a position in AGL in Q1 2023 and held it in 4 quarters. The position peaked at $22.6M in Q1 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • HRT Financial reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 22,607 Agilon Health shares in Q1 2026, an estimated $389K.
  • HRT Financial first reported a position in Agilon Health in Q1 2023 and held it in 4 quarters.
  • HRT Financial's Agilon Health position peaked at $22.6M in Q1 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.